Shenzhen 999 Chinese Medicine Investment & Development

Shenzhen Sanjiu Traditional Chinese Medicine Investment & Development is a subsidiary of China Resources Sanjiu Medical & Pharmaceutical, specializing in the investment and industrialization of Traditional Chinese Medicine (TCM). The company focuses on the entire TCM value chain, including the cultivation of medicinal herbs, the development of standardized processing techniques, and the production of TCM formula granules. It plays a vital role in the parent company's strategy to modernize TCM through scientific research and quality control. The company's products support the well-known 999 brand, which is a leader in the Chinese consumer healthcare market for respiratory and digestive ailments.